BSECompany Update9h ago · 11 Aug 2026, 07:02 pm

Regulation 32-Nil variation statement

Ganesh Benzoplast Ltd · 500153

✦ AI SummaryDebt Restruc.

Ganesh Benzoplast Ltd has filed a statement of deviation or variation in the utilization of funds raised through a preferential issue for the quarter ended June 30, 2026. The company has reported a deviation in the use of funds for one of the preferential issues, but not for the other. The deviation is due to a change in the objects of the issue, which was approved by the shareholders on September 25, 2025.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Ganesh Benzoplast Ltd - 500153 - Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of SEBI (LODR) Regulations, 2015

Attachments (1)

📄

f19217c8-acd6-47dd-ae2b-8c09c70a4ea4.pdf

pdf

Download →
View document text
GANESH BENZOPLAST LIMITED CIN: L24200MH1986PLC039836 Regd. Office: Dina Building, 1st Floor, 53, Maharshi Karve Road, Marine Lines, Mumbai - 400 002 Tel: 022- 6140 6000/22001928 Email: compliance@gblinfra.com Website: www.ganeshbenzoplast.com August 11, 2026 The General Manager, The Manager, Department of Corporate Services – Listing Department Corporate Relations Department, National Stock Exchange of India Limited BSE Limited, Exchange Plaza, 5th Floor, Pheeroze Jeejeebhoy Towers, Plot No. C/1, G-Block, Bandra Kurla Dalal Street, Fort, Complex, Mumbai – 400 001. Bandra (E), Mumbai – 400051 Scrip ID: 500153 Scrip ID: GANESHBE Dear Sir, Sub: Statement of Deviation or Variation in Utilization of Funds under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) for the Quarter ended June 30, 2026 Pursuant to Regulation 32 and other applicable provisions of the SEBI (LODR) Regulations, 2015 read with SEBI circulars issued in this regard, please find enclosed herewith the Statement of Deviation or Variation in utilization of funds raised through preferential issue by the Company for the First quarter ended June 30, 2026. We hereby confirm that there has been no Deviation or Variation in the use of proceeds of funds raised through preferential issue. We request you to kindly take the above information on your record. Thanking you, Yours Faithfully, For Ganesh Benzoplast Ltd. Rishi Pilani Chairman & Managing Director (DIN 00901627) Encl: As above Corp Office: 501/ 502, 'C' Wing, Lotus Corporate Park, Off. Western Express Highway, Laxmi Nagar, Goregaon (East), Mumbai - 400063. B. Statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. – Statement of Deviation / Variation In utilisation of funds raised Name of listed entity GANESH BENZOPLAST LIMITED Mode of Fund Raising Preferential Issue of Equity Shares Date of Raising Funds 01-03-2024 Amount Raised Rupees 324.00 million Report filed for Quarter ended June 30,2026 Monitoring Agency Not Applicable Monitoring Agency Name, if applicable Not Applicable Is there a Deviation / Variation in use of funds raised No If yes, whether the same is pursuant to change in terms Not Applicable of a contract or objects, which was approved by the shareholders If Yes, Date of shareholder Approval Not Applicable Explanation for the Deviation / Variation Not Applicable Comments of the Audit Committee after review NIL Comments of the auditors, if any NIL Objects for which funds have been raised and where there has been a deviation, in the following table Original Object Modified Original Modified Funds Amount of Remarks Object, if any Allocation allocation, if Utilised as on deviation/ if any any June 30, 2026 Variation for quarter according to applicable object For (i) capitalexpenditure and working capital Not Applicable Rs. 324.00 Nil Nil Nil - requirements of the Company, its subsiadries, joint million ventures or associates (ii) funding the Business expansion directly by the Company or through its subsidiaries or joint ventures or associates for the growth of existing businesses or to enter into new business in line with the strategy of the Company and (iii) general corporate purposes of the Company. Deviation or variation could mean: (a) Deviation in the objects or purposes for which the funds have been raised or (b) Deviation in the amount of funds actually utilized as against what was originally disclosed or (c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc. Statement of Deviation / Variation In utilisation of funds raised Name of listed entity GANESH BENZOPLAST LIMITED Mode of Fund Raising Preferential Issue of Equity Shares Date of Raising Funds 12-01-2024 Amount Raised Rupees 303.50 million Report filed for Quarter ended June 30, 2026 Monitoring Agency Not Applicable Monitoring Agency Name, if applicable Not Applicable Is there a Deviation / Variation in use of funds raised Yes If yes, whether the same is pursuant to change in terms of Yes a contract or objects, which was approved by the shareholders If Yes, Date of shareholder Approval 25-09-2025 Explanation for the Deviation / Variation Change in Objects of the Issue Comments of the Audit Committee after review NIL Comments of the auditors, if any NIL Objects for which funds have been raised and where there has been a deviation, in the following table Original Object Modified Object, if any* Original Modified Funds Amount of Remarks Allocation allocation, if Utilised as on deviation/ if any any June 30, 2026 Variation for quarter according to applicable object For LPG Business expansion directly by the Company or i) establishment of Infrastructure for Rs. 303.50 Rs. 303.50 Rs. 279.26 Nil - through its subsidiaries or joint ventures or associates handling Liquids and gases including LPG million million million and other general corporate business requirements. and ammonia tanks; (ii) business expansion, directly or through subsidiaries, joint ventures, or associates, for growth of existing businesses and entry into new opportunities in line with the Company’s strategy; (iii) capital expenditure and working capital requirements of the Company, its subsidiaries, joint ventures, or associates; and (iv) general corporate purposes. Deviation or variation could mean: (a) Deviation in the objects or purposes for which the funds have been raised or (b) Deviation in the amount of funds actually utilized as against what was originally disclosed or (c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc. *Note: Objects of the Issue were modified with the approval of members in Annual General Meeting held on September 25, 2025.However there is no deviation in ulilization of funds.